Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...

Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS ...

In a report released yesterday, Vik Chopra from Wells Fargo assigned a Buy rating to Masimo (MASI – Research Report), with a price target ...

Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares opened today ...

Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in ...

Global medical innovator Masimo has announced a partnership with Google to develop a new reference platform for original ...

MASI's latest partnership is likely to develop a new reference platform that brings high-performing Wear OS smartwatches to market.

Google has now partnered with Masimo and Qualcomm to create health-focused Wear OS reference platforms, integrating Masimo's ...

The future of an iconic Orange County medtech entrepreneur – who was once compared to Steve Jobs – is at stake this week.

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.